-
Myelin Damage Can Remodel Before Sheath Loss
2026-08-28
Arafa et al. show that early CNS myelin damage is often marked by swelling that can resolve rather than inevitably progressing to sheath loss. Across zebrafish, rodent, and human tissue, the study identifies neuronal activity as a modifiable factor that worsens early pathology and provides a framework for testing myelin-protective interventions.
-
ExoU, Lipid Metabolism, and Host Cell Death
2026-08-27
The University of Ottawa thesis investigates how the Pseudomonas aeruginosa toxin ExoU connects phospholipase activity, host lipid remodeling, and cytotoxicity. Its most direct mechanistic finding is that ExoU-expressing bacteria increase lysophosphatidylcholine levels in host cells, while pharmacological tests argue against apoptosis or necroptosis as the dominant explanation for early cell death.
-
Nanoparticle Uptake in Human Corneal Epithelium
2026-08-27
This 2024 ACS study systematically links PLGA nanoparticle size and surface chemistry to uptake by human corneal epithelial cells. Using a mucosal in vitro model and pathway inhibitors, it identifies energy-dependent endocytosis, especially macropinocytosis and caveolae-mediated uptake, as the dominant mechanisms.
-
Autophagy–Liver Metastasis Signature in CRC
2026-08-26
Bai et al. integrated bulk and single-cell transcriptomic data to develop a six-gene colorectal cancer signature associated with autophagy, liver metastasis, prognosis, and immune dysfunction. The study links high-risk classification with immunosuppressive macrophage and CD8+ T-cell states, while providing a framework for evaluating treatment response and tumor microenvironment heterogeneity.
-
Neomycin sulfate: Workflow for Structure Studies
2026-08-26
Neomycin sulfate is an aminoglycoside antibiotic that can serve as a mechanistic probe for RNA, DNA, and ion-channel experiments—not merely as a generic antimicrobial. This workflow connects concentration-controlled binding assays with ribozyme, HIV-1 TAR, DNA triplex, and ryanodine receptor applications while emphasizing controls, fresh aqueous preparation, and cross-domain limitations.
-
BIBP 3226 Trifluoroacetate: Cardiac Assays
2026-08-25
BIBP 3226 trifluoroacetate enables pharmacological separation of NPY Y1 and NPFF signaling in cAMP, calcium, and adipose-neural models. This guide translates recent arrhythmia findings into practical workflows, concentration-planning rules, and troubleshooting strategies for cardiovascular, anxiety, and analgesia research.
-
Capsazepine for TRPV1 Ion Channel Research
2026-08-25
Capsazepine is a practical mechanistic probe for separating TRPV1-driven nociception from broader inflammatory and affective pain pathways. This workflow shows how to apply it in calcium imaging, sensory-neuron assays, behavioral models, TRPM8 experiments, and apoptosis studies while controlling for solubility and off-target effects.
-
(R)-MG132 for Proteasome Control
2026-08-24
(R)-MG132 is a functionally inactive MG-132 enantiomer designed to separate proteasome-dependent effects from solvent, peptide-aldehyde, and nonspecific stress responses. Used alongside active MG-132, it adds a rigorous control layer to HNRNPU lactylation, PHGDH regulation, and cancer-metabolism assays.
-
Computational Hapten Design for Dual Toxin Detection
2026-08-24
This 2026 study combines molecular similarity analysis, quantum-chemical calculations, and monoclonal antibody development to create a fluorescent immunochromatographic assay for simultaneous detection of amatoxins and phallotoxins in mushrooms. The resulting assay achieved low nanogram-per-milliliter antibody sensitivities and low microgram-per-kilogram detection limits in mushroom matrices, providing a practical complement to laboratory instrumental analysis.
-
3D Tumor Spheroids for Glioblastoma Stemness
2026-08-23
Chen et al. present a streamlined 96-well 3D-tumor spheroid assay for functional assessment of stem-like phenotypes in glioblastoma cell lines. By replacing a slower two-round sphere-forming workflow with a compact seeding, centrifugation, and imaging procedure, the method supports reproducible mechanistic studies and higher-throughput screening while still requiring orthogonal validation.
-
Neomycin sulfate for RNA, DNA, and Channel Assays
2026-08-22
Neomycin sulfate is an aminoglycoside antibiotic repurposed as a mechanistic probe for structured RNA, DNA triplexes, HIV-1 TAR recognition, and ryanodine receptor conductance. This workflow-focused guide explains how to choose concentrations, separate binding from catalysis, and control matrix effects without confusing exploratory antibiotic exposure with disease-treatment evidence.
-
Xenopus laevis Pluripotency Network Rewiring
2026-08-21
The reference study shows that hybridization rewired early pluripotency regulation in allotetraploid Xenopus laevis through asymmetric activation of homeologous genes and divergent enhancer architectures. Despite this regulatory divergence, combined L- and S-subgenome expression preserves the dosage of core embryonic transcriptional programs, revealing how selection can stabilize development after genome duplication.
-
From Kinases to Condensates: A Translational Playbook
2026-08-21
A mechanistic and strategic framework for using the CK2 and ERK8 inhibitor as a controlled perturbation tool in kinase signaling, protein interaction, and phase-separation research—without overstating an unproven antiviral mechanism.
-
MG-132 (Z-LLL-al) for Proteasome Assays
2026-08-20
MG-132 (Z-LLL-al) provides a cell-permeable way to perturb proteasome-dependent protein turnover while tracking apoptosis, cell cycle arrest, oxidative stress, and mitochondrial quality control. Its most useful application is comparative mechanism testing: pair proteasome inhibition with ubiquitination, LC3, ROS, viability, and mitochondrial readouts rather than treating it as a pathway-specific mitophagy reagent.
-
MCL1 Resistance Biology Meets L1023 Screening
2026-08-20
MCL1-mediated apoptosis resistance is a compelling test case for translating mechanistic oncology findings into pathway-aware screening. This article shows how the DiscoveryProbe™ Anti-cancer Compound Library (SKU: L1023) can support structured comparison of apoptosis, kinase, proteostasis, and mTOR-linked dependencies without mistaking a phenotypic hit for a validated target mechanism.